Want to see CTNM full AI Analyst Report?
Compare Contineum Therapeutics, Inc. Class A (CTNM) vs. Competitors
Comparison Results
| Name | Price | Market Cap | P/E Ratio | Yearly Gain | Analyst Consensus | Analyst Price Target | Compare | Top Analysts' Price Target | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
| CTNMContineum Therapeutics, Inc. Class A | $9.39 | $353.26M | -5.43 | -10.91% | Strong Buy | CTNM | ||||
| TVRDTvardi Therapeutics | $0.79 | $10.58M | -0.28 | -83.00% | Moderate Buy | CTNM vs TVRD | ||||
| CAPRCapricor Therapeutics | $6.38 | $370.93M | -2.60 | 2.74% | Moderate Buy | CTNM vs CAPR | ||||
| DRTSAlpha Tau | $13.06 | $1.21B | -12.56 | 223.27% | Moderate Buy | CTNM vs DRTS | ||||
| IMRXImmuneering | $3.75 | $242.54M | -3.63 | -41.58% | Strong Buy | CTNM vs IMRX | ||||
| ENGNenGene Holdings | $1.53 | $102.53M | -5.46 | -78.02% | Neutral | CTNM vs ENGN |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| CTNM | Contineum Therapeutics, Inc. Class A | 9.39 | -1.26 | -11.83% | |
| TVRD | Tvardi Therapeutics | 0.79 | -3.72 | -82.44% | |
| CAPR | Capricor Therapeutics | 6.38 | 0.31 | 5.11% | |
| DRTS | Alpha Tau | 13.06 | 9.14 | 233.16% | |
| IMRX | Immuneering | 3.75 | -2.81 | -42.91% | |
| ENGN | enGene Holdings | 1.53 | -5.39 | -77.89% |
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts